10 Feb 2026

Introducing aiMOS: AI-Driven Media Optimization for Cell Therapy

Name: Introducing aiMOS: AI-Driven Media Optimization for Cell Therapy
Uploaded: 2026-03-13T18:47:00Z
Description: GeminiBio and Tolemy Bio will introduce aiMOS™, an AI-driven media optimization service that helps teams reduce variability, increase performance, and improve manufacturability.

GeminiBio Stand: 545

View all ATW26 Content

Breaking the Bottleneck: Solving Late-Stage AAV Challenges with Real World Commercial Experience
Limula: a platform to streamline cell therapy manufacturing, from R&D to the clinic

Introducing aiMOS: AI-Driven Media Optimization for Cell Therapy

Phacilitate’s Next Global Meeting: